Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective study of PHP Therapy in patients with Metastatic Ocular Melanoma after Chemosaturation Percutaneous Hepatic Perfusion

Trial Profile

A retrospective study of PHP Therapy in patients with Metastatic Ocular Melanoma after Chemosaturation Percutaneous Hepatic Perfusion

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2018

At a glance

  • Drugs Melphalan (Primary)
  • Indications Liver metastases; Uveal melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2018 New trial record
    • 24 Sep 2018 According to a Delcath Systems media release, the study was conducted by M. Zeile, and A. Stang of the Asklepios Barmbek Clinic in Hamburg, Germany.
    • 24 Sep 2018 According to a Delcath Systems media release, data from this study presented as a poster at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) annual meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top